<div align="center">

# üß¨ Sanjeevani

### AI-Powered Pharmacogenomic Risk Prediction System

*"Sanjeevani" ‚Äî the mythical herb from Indian mythology that could bring the dead back to life.*
*We believe the right genetic information, at the right time, can save lives.*

[![RIFT 2026](https://img.shields.io/badge/RIFT_2026-Hackathon-green?style=for-the-badge)](https://rift2026.com)
[![HealthTech](https://img.shields.io/badge/Track-HealthTech_PS3-blue?style=for-the-badge)](https://rift2026.com)
[![Next.js](https://img.shields.io/badge/Next.js-14-black?style=for-the-badge&logo=nextdotjs)](https://nextjs.org)
[![Gemini](https://img.shields.io/badge/Google_Gemini-2.0_Flash-orange?style=for-the-badge&logo=google)](https://ai.google.dev)
[![License](https://img.shields.io/badge/License-MIT-yellow?style=for-the-badge)](LICENSE)

**Team NextGen** ‚Äî Vishwas H V ¬∑ Tarun Kumar ¬∑ Vankadara Navneet ¬∑ Shanmukeswar Reddy

</div>

---

## üîó Submission Links

| # | Requirement | Link |
|---|-------------|------|
| 1 | **Live Demo** | [Deployed URL ‚Äî Coming Soon] |
| 2 | **LinkedIn Video** | [Video Link ‚Äî Coming Soon] |
| 3 | **GitHub Repository** | [github.com/vishwash-v/Sanjeevani](https://github.com/vishwash-v/Sanjeevani) |
| 4 | **README.md** | You're reading it! |

---

## üìã Table of Contents

- [The Problem](#-the-problem)
- [Our Solution](#-our-solution-sanjeevani)
- [Key Features](#-key-features)
- [Architecture](#-system-architecture)
- [How It Works ‚Äî Technical Pipeline](#-how-it-works--technical-pipeline)
- [Supported Drug‚ÄìGene Pairs](#-supported-druggene-pairs)
- [Privacy & Security](#-privacy--security)
- [Error Handling](#-error-handling)
- [Tech Stack](#-tech-stack)
- [Installation & Setup](#-installation--setup)
- [Usage Guide](#-usage-guide)
- [Sample VCF Files](#-sample-vcf-files-for-testing)
- [API Documentation](#-api-documentation)
- [Data Sources & References](#-data-sources--references)
- [What Makes Sanjeevani Unique](#-what-makes-sanjeevani-unique)
- [Challenges We Faced](#-challenges-we-faced)
- [Team](#-team-nextgen)
- [Disclaimer](#%EF%B8%8F-disclaimer)

---

## üö® The Problem

**Adverse drug reactions (ADRs) are the 4th leading cause of death in hospitals.** Every year, over 2 million people are hospitalized due to medications that interact dangerously with their genetic makeup. A painkiller that works perfectly for one patient can cause fatal respiratory depression in another ‚Äî not because of the wrong diagnosis, but because of invisible genetic differences in how their bodies metabolize drugs.

The science to prevent this already exists. **Pharmacogenomics** ‚Äî the study of how genes affect drug response ‚Äî is a mature field with peer-reviewed guidelines published by the Clinical Pharmacogenomics Implementation Consortium (CPIC). These guidelines cover dozens of drugs and clearly specify: *"If the patient has this genotype, adjust the dosage / avoid this drug / use an alternative."*

**But there's a gap.** Clinicians don't have time to manually:
1. Parse raw VCF genomic files
2. Identify pharmacogenomic variants among thousands of records
3. Call star alleles from detected variants
4. Calculate activity scores and metabolizer phenotypes
5. Cross-reference CPIC dosing guidelines
6. Explain the results in patient-friendly language

**This gap between available knowledge and clinical practice is costing lives. Sanjeevani bridges it.**

---

## üí° Our Solution: Sanjeevani

Sanjeevani is a **complete, end-to-end pharmacogenomic risk prediction system** that takes a patient's raw VCF file and produces clinically actionable drug safety assessments in seconds.

### What happens when you upload a VCF file:

```
Patient VCF File ‚îÄ‚îÄ‚Üí Parse & Validate ‚îÄ‚îÄ‚Üí Extract Pharma Variants ‚îÄ‚îÄ‚Üí Call Star Alleles
     ‚îÇ                                                                        ‚îÇ
     ‚ñº                                                                        ‚ñº
  Quality Filter              Map to 6 Pharmacogenes              Calculate Activity Score
  (QUAL, DP, GQ)              (CYP2D6, CYP2C19, etc.)            (CPIC Consensus Method)
                                                                        ‚îÇ
                                                                        ‚ñº
                               Assign Metabolizer Phenotype ‚óÑ‚îÄ‚îÄ‚îÄ‚îÄ Gene-Specific Thresholds
                               (Poor/Intermediate/Normal/Rapid/Ultra-Rapid)
                                                                        ‚îÇ
                                                                        ‚ñº
                               Multi-Factor Risk Engine ‚îÄ‚îÄ‚Üí Risk Label + Confidence Score
                               (Safe / Adjust Dosage / Toxic / Ineffective)
                                                                        ‚îÇ
                                                                        ‚ñº
                               Gemini 2.0 Flash AI ‚îÄ‚îÄ‚Üí Plain Language Clinical Explanation
                               (anonymized data only)         (mechanism + recommendation)
```

**The entire pipeline processes a full VCF file in under 3 seconds.**

---

## ‚ú® Key Features

### 1. üß™ Production-Grade VCF Parser (v5 ‚Äî Edge-Case Hardened)
Our custom-built VCF parser handles **7 validated exception scenarios** that real-world clinical VCF files throw at you:

| Exception | How Sanjeevani Handles It |
|-----------|--------------------------|
| **Low quality variants** (QUAL < 20) | Filtered out with warning ‚Äî prevents false positives from sequencing noise |
| **Failed FILTER** (not PASS) | Skipped ‚Äî only quality-controlled variants are used |
| **Low read depth** (DP < 10) | Skipped with warning ‚Äî insufficient sequencing coverage |
| **Missing rsID** | Falls back to chr:pos coordinate matching against PharmVar/dbSNP |
| **FORMAT/SAMPLE mismatch** | Handles gracefully ‚Äî uses available fields with warning |
| **chr prefix inconsistency** | Normalizes `chr22` ‚Üí `22` automatically |
| **Empty/malformed VCF** | Clear, user-friendly error messages |

Additionally:
- **Dual genome build support**: Auto-handles both **GRCh37** (hg19) and **GRCh38** (hg38)
- **Genotype quality (GQ) warnings**: Flags unreliable genotype calls (GQ < 15)
- **0/0 genotype filtering**: Homozygous reference (0/0) variants are correctly excluded from detected variants ‚Äî only actual mutations (0/1, 1/1) are reported
- **Multi-allelic site handling**: Properly processes complex genotypes

### 2. üéØ CPIC-Aligned Star Allele Calling
- Maps detected variants to **27 pharmacogenomic variant definitions** across 6 genes
- Supports **compound heterozygous resolution** (e.g., CYP2C19 *2 + *3 = *2/*3 ‚Üí Poor Metabolizer)
- Uses **weighted matching** for partial variant hits
- Properly distinguishes heterozygous (0/1) from homozygous (1/1) for diplotype construction

### 3. üìä Multi-Factor Risk Engine (Not a Simple Lookup Table)
Our risk engine goes beyond basic phenotype-to-risk mapping:

- **Activity Score Calculation** following CPIC's standardized methodology (Caudle et al., 2017)
- **Gene-specific phenotype thresholds** aligned with the latest CPIC consensus:
  - CYP2D6: Caudle 2024 update (AS=1 ‚Üí IM, previously NM)
  - CYP2C19: Lee 2022
  - CYP2C9: Johnson 2017
  - DPYD: Amstutz 2018
  - TPMT: Relling 2019
  - SLCO1B1: Cooper-DeHoff 2022
- **Drug-specific pharmacology**: The same phenotype can mean "Toxic" for one drug and "Ineffective" for another (e.g., CYP2D6 PM ‚Üí Codeine is Toxic, but CYP2C19 PM ‚Üí Clopidogrel is Ineffective)
- **ML-calibrated confidence scoring**: Honestly reports prediction certainty based on variant count, functional impact, and activity score extremity
- **Severity escalation**: Automatically escalates severity when multiple no-function variants are detected

### 4. ü§ñ Google Gemini 2.0 Flash AI Explanations
- Generates **structured clinical explanations** with mechanism of action, variant-specific effects, and clinical context
- Uses **structured JSON output** (not free-form text) for consistency
- Sends only **anonymized summaries** (drug, gene, diplotype, risk) ‚Äî never raw VCF data
- **Graceful fallback**: If no API key is configured or the API fails, pre-computed CPIC-based explanations are used automatically

### 5. üè• Clinical Accuracy Measures
- **SLCO1B1 correctly identified as a hepatic uptake transporter** (OATP1B1), not an enzyme
- **Panel limitation disclaimers**: Warfarin results note that VKORC1 is not tested; Azathioprine results note that NUDT15 is not tested
- **CPIC clinical action terms** sourced directly from published guidelines
- **Alternative drug recommendations** for every unsafe result
- **Clinical disclaimer** on every analysis output

### 6. üîí Privacy-First Architecture (Zero Storage)

```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                 YOUR DEVICE (Browser)                    ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê    ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê    ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê   ‚îÇ
‚îÇ  ‚îÇ VCF File  ‚îÇ‚îÄ‚îÄ‚îÄ‚ñ∂‚îÇ VCF Parser ‚îÇ‚îÄ‚îÄ‚îÄ‚ñ∂‚îÇ  Risk Engine   ‚îÇ   ‚îÇ
‚îÇ  ‚îÇ (raw DNA) ‚îÇ    ‚îÇ (in-memory)‚îÇ    ‚îÇ (CPIC lookup)  ‚îÇ   ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò    ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò    ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò   ‚îÇ
‚îÇ       ‚ùå Never                              ‚îÇ            ‚îÇ
‚îÇ       stored                               ‚ñº            ‚îÇ
‚îÇ                              ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê   ‚îÇ
‚îÇ                              ‚îÇ Drug + Gene + Risk    ‚îÇ   ‚îÇ
‚îÇ                              ‚îÇ (anonymized summary)  ‚îÇ‚îÄ‚îÄ‚îÄ‚îº‚îÄ‚îÄ‚ñ∂ Gemini AI
‚îÇ                              ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò   ‚îÇ   (explanation
‚îÇ                                                         ‚îÇ    only)
‚îÇ  ‚úÖ Raw VCF never leaves     ‚úÖ No database             ‚îÇ
‚îÇ  ‚úÖ No cookies/tracking      ‚úÖ Auto-purge on close     ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

| Privacy Guarantee | How It's Implemented |
|-------------------|---------------------|
| **Zero Storage** | No database, no file system. VCF data exists only in memory during analysis |
| **Genomic Isolation** | Raw VCF never reaches the AI ‚Äî only anonymized drug/gene/risk summaries |
| **Session Purge** | All data auto-clears on tab close + manual "Clear All Data" button |
| **No Tracking** | Zero cookies, zero analytics, zero third-party scripts |
| **API Transparency** | Every response includes `privacy.data_stored: false` metadata |

### 7. üé® Premium UI/UX Design
- **Apple-inspired glassmorphic design** with frosted glass panels and mesh gradient backgrounds
- **Framer Motion animations** throughout ‚Äî smooth transitions, staggered card reveals
- **Full dark mode** with separate design tokens and color palettes
- **Interactive risk spectrum** showing where the patient falls on the Toxic ‚Üê ‚Üí Safe ‚Üê ‚Üí Ineffective scale
- **Expandable AI explanation cards** with structured clinical breakdowns
- **VCF parse warnings panel** with severity-coded icons (‚úï error, ‚ö† warning, ‚Ñπ info)
- **One-click JSON export** for integration with clinical EHR systems
- **Responsive design** that works on desktop, tablet, and mobile
- **Sanjeevani watermark** visible in both light and dark modes

### 8. üõ°Ô∏è Comprehensive Error Handling
- **Frontend validation**: File type (`.vcf` only), file size (5MB max), drug selection required
- **User-friendly error messages** ‚Äî not generic "something went wrong" but specific, actionable guidance
- **Graceful missing annotation handling** ‚Äî missing rsID, QUAL, FILTER, FORMAT fields all handled with warnings
- **Network error handling** with clear retry guidance
- **VCF parse warnings** displayed in a collapsible panel with line numbers and field names

---

## üèóÔ∏è System Architecture

```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                  Next.js 14 Frontend                      ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îÇ
‚îÇ  ‚îÇVCF Upload ‚îÇ  ‚îÇDrug Select‚îÇ  ‚îÇ  Results Dashboard    ‚îÇ  ‚îÇ
‚îÇ  ‚îÇ(drag/drop)‚îÇ  ‚îÇ(6 drugs)  ‚îÇ  ‚îÇ  (risk cards + AI)    ‚îÇ  ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îÇ
‚îÇ        ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò              ‚îÇ
‚îÇ                        ‚ñº                                  ‚îÇ
‚îÇ              Next.js API Route                            ‚îÇ
‚îÇ              POST /api/analyze                            ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê ‚îÇ
‚îÇ  ‚îÇ VCF Parser ‚îÇ  ‚îÇRisk Engine ‚îÇ  ‚îÇ LLM Service          ‚îÇ ‚îÇ
‚îÇ  ‚îÇ (v5, 7    ‚îÇ‚Üí ‚îÇCPIC Rules  ‚îÇ‚Üí ‚îÇ Gemini 2.0 Flash     ‚îÇ ‚îÇ
‚îÇ  ‚îÇ exceptions)‚îÇ  ‚îÇML Scoring  ‚îÇ  ‚îÇ (structured output)  ‚îÇ ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò ‚îÇ
‚îÇ        ‚Üë                 ‚Üë                                ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê                           ‚îÇ
‚îÇ  ‚îÇ 27 Variant ‚îÇ  ‚îÇ 6 Drug-Gene‚îÇ                           ‚îÇ
‚îÇ  ‚îÇ Definitions‚îÇ  ‚îÇ Risk Tables‚îÇ                           ‚îÇ
‚îÇ  ‚îÇ (PharmVar) ‚îÇ  ‚îÇ (CPIC)     ‚îÇ                           ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò                           ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

### Core Modules

| Module | File | Lines | Purpose |
|--------|------|-------|---------|
| **VCF Parser** | `src/lib/vcf-parser.ts` | ~492 | Parse VCF v4.x, quality filtering, variant extraction, star allele calling, gene profile building |
| **CPIC Data** | `src/lib/cpic-data.ts` | ~514 | 27 variant definitions, dual-build coordinates, activity score thresholds, risk profiles, mechanism templates |
| **Risk Engine** | `src/lib/risk-engine.ts` | ~225 | Multi-factor risk computation, confidence scoring, wild-type inference, clinical recommendations |
| **LLM Service** | `src/lib/llm-service.ts` | ~198 | Gemini API integration, structured prompt engineering, fallback explanations |
| **Type System** | `src/lib/types.ts` | ~113 | TypeScript interfaces matching the required JSON output schema exactly |
| **API Route** | `src/app/api/analyze/route.ts` | ~137 | Request validation, pipeline orchestration, privacy metadata |
| **Frontend** | `src/app/page.tsx` | ~800 | Full interactive UI with drag-drop, animations, risk visualization |

---

## üî¨ How It Works ‚Äî Technical Pipeline

### Step 1: VCF Parsing & Quality Control
```
Raw VCF ‚Üí Line-by-line parsing ‚Üí Quality filtering (QUAL‚â•20, FILTER=PASS, DP‚â•10)
        ‚Üí FORMAT/SAMPLE extraction ‚Üí Genotype (GT) calling ‚Üí Chromosome normalization
```
- Supports VCF v4.x format
- Auto-detects genome build from header
- Handles tab-separated and whitespace-separated formats
- Filters 0/0 genotypes (homozygous reference = variant NOT present)

### Step 2: Pharmacogenomic Variant Identification
```
Parsed Records ‚Üí rsID match (highest priority) ‚Üí chr:pos match (fallback)
              ‚Üí ¬±5bp fuzzy match (for indels) ‚Üí Gene INFO tag match (last resort)
```
- Matches against **27 curated variant definitions** from PharmVar + dbSNP
- Supports both GRCh37 and GRCh38 coordinates simultaneously
- Deduplicates star alleles from multiple defining SNPs

### Step 3: Star Allele Calling & Diplotype Construction
```
Matched Variants ‚Üí Group by gene ‚Üí Determine allele activities
                ‚Üí Resolve compound heterozygotes ‚Üí Build diplotype string
```
- **Homozygous variant** (1/1): Both alleles carry the variant ‚Üí e.g., *4/*4
- **Heterozygous variant** (0/1): One variant + one wild-type ‚Üí e.g., *1/*4
- **Compound heterozygous**: Two different heterozygous variants in same gene ‚Üí e.g., *2/*3

### Step 4: Activity Score ‚Üí Phenotype Translation
```
Allele 1 Activity + Allele 2 Activity = Total Activity Score
                                         ‚Üí Gene-specific CPIC threshold
                                         ‚Üí Metabolizer Phenotype
```

| Gene | Poor Metabolizer | Intermediate | Normal | Rapid/Ultra-Rapid |
|------|-----------------|--------------|--------|-------------------|
| CYP2D6 | AS = 0 | AS 0.25‚Äì1.0 | AS 1.25‚Äì2.25 | AS > 2.25 |
| CYP2C19 | AS = 0 | AS 0.5‚Äì1.0 | AS 1.5‚Äì2.0 | AS > 2.0 |
| CYP2C9 | AS ‚â§ 0.5 | AS 1.0‚Äì1.5 | AS = 2.0 | ‚Äî |
| SLCO1B1 | AS = 0 | AS ‚â§ 1.0 | AS ‚â• 1.5 | ‚Äî |
| TPMT | AS = 0 | AS ‚â§ 1.0 | AS ‚â• 1.5 | ‚Äî |
| DPYD | AS ‚â§ 0.5 | AS 1.0‚Äì1.5 | AS = 2.0 | ‚Äî |

### Step 5: CPIC Risk Assessment
The risk engine maps phenotype + drug-specific pharmacology to a clinical risk label:

| Drug | PM Risk | Why |
|------|---------|-----|
| **Codeine** | Toxic | Can't convert codeine ‚Üí morphine, parent drug accumulates |
| **Clopidogrel** | Ineffective | Can't bioactivate prodrug ‚Üí no antiplatelet effect |
| **Warfarin** | Adjust Dosage | Slow clearance, but titratable with INR monitoring |
| **Simvastatin** | Adjust Dosage | Impaired hepatic uptake ‚Üí systemic exposure ‚Üë |
| **Azathioprine** | Toxic | Deficient TPMT ‚Üí TGN accumulation ‚Üí myelosuppression |
| **Fluorouracil** | Toxic | DPD deficiency ‚Üí >10x 5-FU exposure ‚Üí fatal toxicity |

### Step 6: AI Clinical Explanation
```
Anonymized Result ‚Üí Structured Prompt ‚Üí Gemini 2.0 Flash ‚Üí JSON Response
(drug + gene +        (5-field schema)    (temp=0.3,         (summary, mechanism,
 risk only)                                structured output)  effects, context, refs)
```

---

## üíä Supported Drug‚ÄìGene Pairs

| Drug | Gene | Clinical Use | What Genetics Can Reveal |
|------|------|-------------|------------------------|
| **Codeine** | CYP2D6 | Pain relief | Poor Metabolizers get zero benefit; Ultra-Rapid Metabolizers risk fatal morphine toxicity |
| **Warfarin** | CYP2C9 | Blood clot prevention | Wrong dose = dangerous bleeding or stroke. *Note: VKORC1 not tested by this panel* |
| **Clopidogrel** | CYP2C19 | Heart attack/stroke prevention | Poor Metabolizers can't activate the drug ‚Äî stents may clot |
| **Simvastatin** | SLCO1B1 | Cholesterol management | Impaired transporter ‚Üí 2-4x drug exposure ‚Üí rhabdomyolysis risk |
| **Azathioprine** | TPMT | Autoimmune diseases | Poor Metabolizers accumulate toxic metabolites ‚Üí bone marrow failure. *Note: NUDT15 not tested* |
| **Fluorouracil** | DPYD | Cancer chemotherapy | DPD deficiency ‚Üí severe, potentially fatal toxicity |

---

## üõ°Ô∏è Error Handling

### Frontend Validation
| Check | Error Message |
|-------|--------------|
| Non-.vcf file | *"Please upload a valid .vcf file. Only VCF (Variant Call Format) files are supported."* |
| File > 5MB | *"File too large. Maximum file size is 5MB."* |
| No file uploaded | *"Please upload a VCF file before analyzing."* |
| No drugs selected | *"Please select at least one drug to analyze."* |
| Network failure | *"Network error. Please check your connection and try again."* |

### Backend Validation
| Check | Error Message |
|-------|--------------|
| Empty VCF | *"VCF file is empty"* |
| Headers only | *"No actionable pharmacogenomic variants found..."* |
| All filtered | *"No variants passed quality filters..."* |
| Invalid format | Line-specific warnings with field names |

### Graceful Degradation
| Missing Data | Handling |
|-------------|---------|
| No rsID | Falls back to chr:pos matching |
| No QUAL score | Processes with lower confidence |
| No FORMAT/SAMPLE | Defaults genotype, shows warning |
| No Gemini API key | Uses pre-computed CPIC explanations |
| Gemini API failure | Falls back silently to pre-computed explanations |

---

## üõ†Ô∏è Tech Stack

| Layer | Technology | Why |
|-------|-----------|-----|
| **Framework** | Next.js 14 (App Router) | Server-side API routes + React in one codebase |
| **Language** | TypeScript (strict) | Type safety is critical for genomic/medical data |
| **AI/LLM** | Google Gemini 2.0 Flash | Fast structured JSON output, handles medical terminology |
| **UI Animations** | Framer Motion | Smooth GPU-accelerated animations for glassmorphic design |
| **Styling** | Custom CSS Design System | Apple-inspired liquid glass tokens, not a template |
| **Icons** | Lucide React | Clean, consistent medical/scientific iconography |
| **VCF Parser** | Custom TypeScript (v5) | No existing parser handled our 7 edge cases |
| **Risk Engine** | Custom TypeScript | CPIC-aligned algorithmic risk with ML confidence scoring |

---

## üöÄ Installation & Setup

### Prerequisites
- **Node.js** 18+ (recommended: 22.x)
- **npm** or **yarn**

### Quick Start

```bash
# 1. Clone the repository
git clone https://github.com/vishwash-v/Sanjeevani.git
cd pharma-guard

# 2. Install dependencies
npm install

# 3. Set up environment variables
cp .env.example .env.local
# Edit .env.local and add your Gemini API key (optional)

# 4. Run the development server
npm run dev
```

Open **[http://localhost:3000](http://localhost:3000)** and you're ready to go!

### Environment Variables

| Variable | Description | Required |
|----------|-------------|----------|
| `GEMINI_API_KEY` | Google Gemini API key for AI explanations | **Optional** ‚Äî fallback explanations work without it |

> üí° **Don't have a key?** Sanjeevani works perfectly without one ‚Äî you'll get pre-computed CPIC-based explanations. Get a free key at [aistudio.google.com/apikey](https://aistudio.google.com/apikey) for the full AI experience.

### Deployment

Sanjeevani deploys to **Vercel** with zero configuration:

```bash
npm install -g vercel
vercel --prod
```

Add `GEMINI_API_KEY` in Vercel Environment Variables settings.

---

## üìñ Usage Guide

### Step-by-Step

1. **Upload VCF File** ‚Äî Drag & drop or click to browse (supports VCF v4.x, max 5MB)
2. **Select Drugs** ‚Äî Choose one or more of the 6 supported drugs (or "Select All")
3. **Analyze** ‚Äî Click "Analyze Pharmacogenomic Risk" and wait ~3 seconds
4. **Review Results** ‚Äî Each drug gets a risk card with:
   - Risk label (color-coded: green=Safe, yellow=Adjust, red=Toxic, gray=Ineffective)
   - Interactive risk spectrum bar
   - Confidence score
   - Diplotype and phenotype
   - Detected variants with rsIDs and clinical significance
   - AI-generated clinical explanation (expandable)
   - CPIC guideline reference
5. **Export** ‚Äî Copy JSON to clipboard or download as file

### Quick Demo
Click **"Try a sample file"** in the upload area to load a pre-configured VCF with compound heterozygous CYP2C19 variants.

---

## üìÅ Sample VCF Files for Testing

All sample files are included in `public/sample-vcf/`:

### Clinical Scenarios
| File | Expected Result |
|------|----------------|
| `sample_patient.vcf` | Multiple high-risk alerts across all 6 genes |
| `cyp2d6_poor_metabolizer_grch38.vcf` | **Toxic** for Codeine ‚Äî CYP2D6 *4/*4 (Poor Metabolizer) |
| `multi_gene_grch38.vcf` | High risk across multiple drugs simultaneously |
| `normal_metabolizer_grch38.vcf` | **Safe** ‚Äî demonstrates normal function variants |

### Exception Test Cases (`public/sample-vcf/exceptions/`)
| File | What It Tests |
|------|---------------|
| `exception_chr_prefix.vcf` | Chromosome prefix normalization (chr22 ‚Üí 22) |
| `exception_compound_het.vcf` | Compound heterozygous detection (*2/*3) |
| `exception_empty.vcf` | Empty file handling |
| `exception_format_mismatch.vcf` | FORMAT/SAMPLE field count mismatch |
| `exception_low_qual.vcf` | Low quality variant filtering |
| `exception_missing_gene.vcf` | Missing GENE INFO tag fallback |
| `exception_multi_gene.vcf` | Multi-gene same-file handling |

---

## üì° API Documentation

### `POST /api/analyze`

Analyze a VCF file for pharmacogenomic risks.

**Request**: `multipart/form-data`

| Field | Type | Description |
|-------|------|-------------|
| `vcfFile` | File | VCF file (.vcf), max 5MB |
| `drugs` | String | Comma-separated drug names (e.g., `CODEINE,WARFARIN`) |

**Response** (JSON):

```json
{
  "success": true,
  "results": [
    {
      "patient_id": "PATIENT_XXX",
      "drug": "CODEINE",
      "timestamp": "2026-02-20T...",
      "risk_assessment": {
        "risk_label": "Toxic",
        "cpic_clinical_action": "Avoid codeine use",
        "confidence_score": 0.85,
        "severity": "critical"
      },
      "pharmacogenomic_profile": {
        "primary_gene": "CYP2D6",
        "diplotype": "*4/*4",
        "phenotype": "PM",
        "detected_variants": [
          {
            "rsid": "rs3892097",
            "chromosome": "22",
            "position": 42128945,
            "ref_allele": "C",
            "alt_allele": "T",
            "genotype": "1/1",
            "gene": "CYP2D6",
            "clinical_significance": "*4: Splicing defect ‚Äî complete loss of enzyme activity [rsID]"
          }
        ]
      },
      "clinical_recommendation": {
        "action": "AVOID CODEINE...",
        "dosing_guidance": "...",
        "alternative_drugs": ["Acetaminophen", "NSAIDs", "Morphine (direct)"],
        "monitoring_recommendations": "...",
        "cpic_guideline_reference": "CPIC Guideline for CYP2D6 and Codeine (Crews et al., 2021)"
      },
      "llm_generated_explanation": {
        "summary": "...",
        "mechanism": "...",
        "variant_specific_effects": "...",
        "clinical_context": "...",
        "references": ["..."]
      },
      "quality_metrics": {
        "vcf_parsing_success": true,
        "variants_detected": 1,
        "pharmacogenes_found": 1,
        "llm_explanation_generated": true,
        "processing_time_ms": 1250
      }
    }
  ],
  "vcf_warnings": [...],
  "meta": {
    "total_drugs_analyzed": 1,
    "llm_enabled": true,
    "privacy": {
      "data_stored": false,
      "raw_vcf_sent_to_llm": false,
      "session_only": true
    }
  },
  "methodology": {
    "risk_label_derivation": "Algorithmically computed from genotype-to-phenotype translation using CPIC-standardized activity scores...",
    "data_sources": ["CPIC", "PharmVar", "dbSNP", "PharmGKB"]
  },
  "clinical_disclaimer": "Risk labels are algorithmically derived..."
}
```

### `POST /api/parse-vcf` (Debug Endpoint)

Returns raw parsing output for debugging ‚Äî shows every parsed record, matched variants, gene profiles, and parse warnings.

---

## üìö Data Sources & References

### Pharmacogenomics Databases

| Source | Usage | License |
|--------|-------|---------|
| [CPIC](https://cpicpgx.org/) | Star allele functional status, activity values, dosing guidelines | Open Access |
| [PharmGKB](https://www.pharmgkb.org/) | Clinical annotations, gene-drug evidence levels | CC BY-SA 4.0 |
| [PharmVar](https://www.pharmvar.org/) | Star allele definitions, variant nomenclature | Open Access |
| [NCBI dbSNP](https://www.ncbi.nlm.nih.gov/snp/) | Variant rsIDs, GRCh37/GRCh38 genome coordinates | Public Domain |

### CPIC Clinical Guidelines

1. **Crews KR, et al.** (2021). CPIC Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. *Clin Pharmacol Ther*, 110(4), 888‚Äì896. [PMC8249478](https://pmc.ncbi.nlm.nih.gov/articles/PMC8249478/) ‚Äî *CYP2D6 ‚Üí Codeine*

2. **Lee CR, et al.** (2022). CPIC Guideline for CYP2C19 and Clopidogrel Therapy: 2022 Update. *Clin Pharmacol Ther*, 112(5), 959‚Äì967. [PMC9035072](https://pmc.ncbi.nlm.nih.gov/articles/PMC9035072/) ‚Äî *CYP2C19 ‚Üí Clopidogrel*

3. **Johnson JA, et al.** (2017). CPIC Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update. *Clin Pharmacol Ther*, 102(3), 397‚Äì404. [PMC5546947](https://pmc.ncbi.nlm.nih.gov/articles/PMC5546947/) ‚Äî *CYP2C9/VKORC1 ‚Üí Warfarin*

4. **Cooper-DeHoff RM, et al.** (2022). CPIC Guideline for SLCO1B1, ABCG2, and CYP2C9 and Statin-Associated Musculoskeletal Symptoms. *Clin Pharmacol Ther*, 111(5), 1007‚Äì1021. [PMC8799009](https://pmc.ncbi.nlm.nih.gov/articles/PMC8799009/) ‚Äî *SLCO1B1 ‚Üí Simvastatin*

5. **Relling MV, et al.** (2019). CPIC Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update. *Clin Pharmacol Ther*, 105(5), 1095‚Äì1105. [PMC6395087](https://pmc.ncbi.nlm.nih.gov/articles/PMC6395087/) ‚Äî *TPMT ‚Üí Azathioprine*

6. **Amstutz U, et al.** (2018). CPIC Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. *Clin Pharmacol Ther*, 103(2), 210‚Äì216. [PMC5760397](https://pmc.ncbi.nlm.nih.gov/articles/PMC5760397/) ‚Äî *DPYD ‚Üí Fluorouracil*

### Methodology References

7. **Caudle KE, et al.** (2017). Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from CPIC and DPWG. *Clin Pharmacol Ther*, 102(1), 33‚Äì36. [PMC5292679](https://pmc.ncbi.nlm.nih.gov/articles/PMC5292679/) ‚Äî *Activity score methodology*

8. **Li B, Sangkuhl K, et al.** (2024). How to Run PharmCAT. *Clin Pharmacol Ther*, 116(5). [PMC9232983](https://pmc.ncbi.nlm.nih.gov/articles/PMC9232983/) ‚Äî *VCF ‚Üí Star allele reference*

9. **Sangkuhl K, et al.** (2020). PharmVar Star Allele Nomenclature. *Clin Pharmacol Ther*, 107(1), 183‚Äì186. [PMC6977333](https://pmc.ncbi.nlm.nih.gov/articles/PMC6977333/) ‚Äî *Nomenclature system*

10. **Bousman CA, et al.** (2023). PGx Clinical Decision Support in EHRs. *Pharmacogenomics*, 24(4), 219‚Äì229. [PMC9840660](https://pmc.ncbi.nlm.nih.gov/articles/PMC9840660/) ‚Äî *CDS patterns*

---

## üèÜ What Makes Sanjeevani Unique

| Aspect | Typical Hackathon Projects | Sanjeevani |
|--------|---------------------------|------------|
| **Input Handling** | Hardcoded sample data | Production-grade VCF parser with 7 exception handlers |
| **Genome Builds** | Single build or none | Dual-build (GRCh37 + GRCh38) with auto-detection |
| **Risk Logic** | Simple if/else or lookup | Multi-factor algorithmic engine with drug-specific pharmacology |
| **Confidence** | Binary yes/no | ML-calibrated confidence scoring (0.40‚Äì0.98) |
| **Star Alleles** | Basic SNP matching | Compound heterozygous resolution, weighted matching |
| **Privacy** | Database storage | Zero-storage, in-memory only, auto-purge |
| **AI Usage** | AI makes decisions | AI only explains ‚Äî risk decisions are algorithmic |
| **Fallback** | Breaks without API key | Full functionality with pre-computed CPIC explanations |
| **Clinical Accuracy** | Generic labels | SLCO1B1=transporter, VKORC1/NUDT15 disclaimers, CPIC citations |
| **Error Handling** | Generic errors | Line-specific warnings with field names and severity levels |

---

## üßó Challenges We Faced

**The VCF parser was our biggest struggle.** We went through **5 iterations** ‚Äî each time real-world VCF files revealed new edge cases: missing FILTER columns, multi-allelic sites, genome builds not declared in headers, genotype quality issues. Version 5 handles 7 distinct exception scenarios because in healthcare, "it works on the happy path" isn't acceptable. 

**Star allele calling is genuinely complex.** Unlike simple SNP lookups, star alleles can involve multiple variants on the same chromosome. We implemented weighted matching that handles partial hits, compound heterozygotes, and quality-weighted confidence ‚Äî a challenge usually tackled by specialized bioinformatics tools like PharmCAT.

**Balancing AI helpfulness with clinical safety.** We wanted Gemini to explain results clearly, but couldn't let it hallucinate medical advice. Our solution: the risk engine makes decisions algorithmically using validated CPIC data, then the LLM receives only the confirmed results for explanation. The AI adds clarity ‚Äî it never makes clinical decisions.

**Clinical accuracy required domain expertise.** Getting details right ‚Äî like SLCO1B1 being a transporter (not an enzyme), or that Codeine PM means toxicity while Clopidogrel PM means ineffectiveness ‚Äî required deep reading of CPIC guidelines. We studied 10+ published papers to ensure every risk label and recommendation matches published clinical evidence.

---

## üë• Team NextGen

| Member | Role |
|--------|------|
| **Vishwas H V** | Lead Developer ‚Äî Architecture, VCF Parser, Risk Engine, UI |
| **Tarun Kumar** | Backend & AI ‚Äî LLM Integration, API Design, Clinical Validation |
| **Vankadara Navneet** | Data & Testing ‚Äî CPIC Data Curation, Sample VCF Creation, QA |
| **Shanmukeswar Reddy** | Frontend & UX ‚Äî Glassmorphic UI, Animations, Dark Mode, Branding |

---

## ‚ö†Ô∏è Disclaimer

Sanjeevani is built for **research and educational purposes only**. It is not a certified medical device and should not replace professional pharmacogenomic consultation. Risk labels are algorithmically derived from CPIC-standardized activity scores and are intended to **assist ‚Äî not replace** ‚Äî clinical decision-making. The prescribing clinician's judgment, informed by published CPIC guidelines, remains the final authority on therapeutic decisions.

---

<div align="center">

Built with sleepless nights and strong coffee ‚òïüß¨

**RIFT 2026 Hackathon** | HealthTech Track | PS3

#RIFT2026 #Sanjeevani #Pharmacogenomics #AIinHealthcare #PrecisionMedicine

</div>
